Back |
home / stock / ebs / ebs message board
Subject | By | Source | When |
---|---|---|---|
7:15AM Emergent BioSolutions BioSolutions announces 'positive' preclinical eff | surf1944 | investorshub | 04/11/2013 1:35:25 PM |
$EBS $13.50 expand front line | mlkrborn | investorshub | 04/05/2013 6:42:25 PM |
stockcharts.com/h-sc/ui | thepostman | investorshub | 01/08/2013 9:43:51 AM |
$EBS $17 on government | mlkrborn | investorshub | 10/03/2011 7:16:02 PM |
Fisher Investments' Healthcare Picks: Large Caps Trumping Small | surf1944 | investorshub | 07/15/2011 2:21:21 AM |
Emergent BioSolutions awarded $106M BioTrax contract from FDA | stockwinner | investorshub | 07/13/2010 8:57:25 PM |
yeah it has been trading around this range | stockwinner | investorshub | 06/25/2010 6:23:16 PM |
$15s now! | mlkrborn | investorshub | 06/25/2010 6:19:18 PM |
Good news so far. I think this is | stockwinner | investorshub | 06/25/2010 6:13:20 PM |
down 1.33 to $13 'cause: | mlkrborn | investorshub | 12/08/2009 3:51:44 PM |
I predict that ebs will move back to | bell345 | investorshub | 06/06/2009 11:12:50 PM |
starting to jump again | dan heil | investorshub | 02/17/2009 6:04:26 AM |
I'm excited about the bios this year because | bell345 | investorshub | 01/08/2009 3:00:03 AM |
Bell: I think you are right. Lets hope | gcanderheggen | investorshub | 01/07/2009 3:19:55 PM |
Biotech is a favorite group now, so EBS | bell345 | investorshub | 01/06/2009 12:57:38 AM |
Bell: Still got a good trend line. Wonder | gcanderheggen | investorshub | 01/05/2009 2:56:33 PM |
Bell: Yes it did and that was during | gcanderheggen | investorshub | 12/13/2008 7:04:04 PM |
News, Short Squeeze, Breakout and More Instantly...
Emergent Biosolutions Inc. Company Name:
EBS Stock Symbol:
NYSE Market:
Emergent Biosolutions Inc. Website:
New video and radio segments raise awareness of a potentially life-saving, three-step method that anyone can use to respond in a suspected opioid poisoning GAITHERSBURG, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch of a new opio...
GAITHERSBURG, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 6, 2024, at 5:00 pm eastern time to discuss the financial results for the second quarter 2024, key business updates, revenue guidance for the third quarter of...
The extension to a four-year shelf-life helps improve naloxone access as communities continue to grapple with the growing opioid epidemic; product with the extended shelf life has officially begun shipping WINNIPEG, Manitoba, July 22, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolution...